Erectile dysfunction and the internet: Drug company manipulation of public and professional opinion

Journal of Sex and Marital Therapy

Volumn 39, Issue 6, 2013, Pages 541-559

  Read, John ^a   Mati, Elizabeth ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

PIPERAZINE DERIVATIVE; PURINE DERIVATIVE; SILDENAFIL; SULFONAMIDE;

ADULT; ADVERTIZING; CONFLICT OF INTEREST; CONSUMER HEALTH INFORMATION; ERECTILE DYSFUNCTION; ETHICS; HEALTH PERSONNEL ATTITUDE; HUMAN; INTERNET; MACHIAVELLIANISM; MALE; MEDICAL ETHICS; MIDDLE AGED; PSYCHOLOGY; PUBLIC OPINION;

ADULT; ADVERTISING AS TOPIC; ATTITUDE OF HEALTH PERSONNEL; CONFLICT OF INTEREST; CONSUMER HEALTH INFORMATION; ERECTILE DYSFUNCTION; ETHICS, PHARMACY; HUMANS; INTERNET; MACHIAVELLIANISM; MALE; MIDDLE AGED; PIPERAZINES; PUBLIC OPINION; PURINES; SILDENAFIL CITRATE; SULFONAMIDES;

EID: 84881317489     PISSN: 0092623X     EISSN: 15210715     Source Type: Journal    
DOI: 10.1080/0092623X.2012.736922     Document Type: Article

References (57)

1. Ahn, T., Park, J., Lee, S., Hong, J., Park, N., Kim, J., and, Hyun, J. 2007. Prevalence and risk factors for erectile dysfunction in Korean men: Results of an epidemiological study. Journal of Sexual Medicine, 4: 1269-1276.
2. Ali, W., Besarani, D., and, Kirby, R. 2002. Modern treatment of erectile dysfunction. British Journal of Diabetes and Vascular Disease, 2: 255-261.
3. Allan, C., Forbes, E., Strauss, B., and, McLachlan, R. 2008. Testosterone therapy increases sexual desire in ageing men with low-normal testosterone levels and symptoms of androgen deficiency. International Journal of Impotence Research, 20: 396-401.
4. Angermeyer, M., Holzinger, A., Carta, M., and, Schomerus, G. 2011. Biogenetic explanations and public acceptance of mental illness. British Journal of Psychiatry, 199: 367-372.
5. Baldwin, D., and, Mayers, A. 2003. Sexual side-effects of antidepressant and antipsychotic drugs. Advances in Psychiatric Treatment, 9: 202-210.
6. Bancroft, J., Carnes, L., Janssen, E., Goodrich, D., and, Long, J. 2005. Erectile and ejaculatory problems in gay and heterosexual men. Archives of Sexual Behavior, 34: 285-297.
7. Banner, L. 2000. The effects of collaborative care in the treatment of erectile dysfunction (ED): An integrative treatment protocol (ITP), Santa Barbara, CA: The Fielding Institute.
8. Barnett, Z., Robleda-Gomez, S., and, Pachana, N. 2012. Viagra: The little blue pill with big repercussions. Aging & Mental Health, 16: 84-88.
9. Bell, R., Taylor, D., and, Kravitz, R. 2010. Do antidepressant advertisements educate consumers and promote communication between patients with depression and their physicians?. Patient Education and Counselling, 81: 132-138.
10. Christensen, B., Grønbæk, M., Osler, M., Pedersen, B., Graugaard, C., and, Frisch, M. 2011. Sexual dysfunctions and difficulties in Denmark: Prevalence and associated sociodemographic factors. Archives of Sexual Behaviour, 40: 121-132.
11. Consumer Reports. 2003. Free rein for drug ads?. Consumer Reports, 68: 33-37.
12. de Wattignar, S., and, Read, J. 2009. The pharmaceutical industry and the Internet: Are drug company funded depression websites biased?. Journal of Mental Health, 18: 1-10.
13. Ernst, E., and, Pittler, M. 1998. Yohimbine for erectile dysfunction: A systematic review and meta-analysis of randomized clinical trials. Journal or Urology, 159: 433-436.
14. Esposito, K., Giugliano, F., Di Palo, C., Giugliano, G., Marfella, R., DAndrea, F., DArmiento, M., and, Giugliano, D. 24. Effect of lifestyle changes on erectile dysfunction in obese men: A randomized controlled trial. Journal of American Medical Association, 291: 2978-2984.
15. Fink, H., MacDonald, R., Rutks, I., Nelson, D., and, Wilt, T. 2002. Sildenafil for male erectile dysfunction: A systematic review and meta-analysis. Archives of Internal Medicine, 162: 1349-1360.
16. Foley, S. 2012. GlaxoSmithKline pays $3bn for illegally marketing depression drug: doctors persuaded to prescribe drug later linked to suicide in children. The Independent,. Retrieved from http://www.independent.co.uk/news/ business/news/glaxosmithkline-pays-3bn-for-illegally-marketing-depression-drug- 7904555.html, July 3
17. Gomes, A., and, Nobre, P. 2012. Early maladaptive schemas and sexual dysfunction in men. Archives of Sexual Behaviour, 41: 311-320.
18. Griffin, M. 2010. DSM-V draft released, pharmaceutical industry influence questioned. Retrieved from http://scitechpolicy.wordpress.com/2010/02/16/dsm-v- draft-releasedpharmaceutical-industry-influence-questioned
19. Griffiths, K., and, Christensen, H. 2000. Quality of web based information on treatment of depression: cross sectional survey. British Medical Journal, 321: 1511-1515.
20. Hanash, K. 2008. New frontiers in men's sexual health: Understanding erectile dysfunction and the revolutionary new treatments, Westport, CT: Praeger.
21. Hawton, K., Catalan, J., and, Fagg, J. 1992. Sex therapy for erectile dysfunction: Characteristics of couples, treatment outcome, and prognostic factors. Archives of Sexual Behavior, 21: 161-175.
22. Jern, P., Gunst, A., Sandnabba, K., and, Santtila, P. 2012. Are early and current erectile problems associated with anxiety and depression in young men? A retrospective self-report study. Journal of Sex & Marital Therapy, 38: 349-364.
23. Johnson, R., and, Shrier, R. 1985. Sexual victimization of boys. Experience at an adolescent medicine clinic. Journal of Adolescent Health Care, 6: 372-376.
24. Khazaal, Y., Chatton, A., Cochand, S., Hoch, A., Khankarli, M., Khan, R., and, Zullino, D. 2008. Internet use by patients with psychiatric disorders in search for general and medical information. Psychiatric Quarterly, 79: 301-309.
25. Kubin, M., Wagner, G., and, Fugl-Meyer, A. 2003. Epidemiology of erectile dysfunction. International Journal of Impotence Research, 15: 63-71.
26. Law, J. 2006. Big pharma: How the world's biggest drug companies control illness, London, England: Constable and Robinson.
27. Londoño, D., Slezak, J., Quinn, V., van den Eeden, K., Loo, R., and, Jacobsen, S. 2011. Population-based study of erectile dysfunction and polypharmacy. British Journal of Urology International, 110: 254-259.
28. Mansell, P., and, Read, J. 2009. Posttraumatic stress disorder, drug companies, and the Internet. Journal of Trauma & Dissociation, 10: 9-23.
29. Masters, W., and, Johnson, V. 1970. Human sexual inadequacy, London, England: Churchill.
30. McCabe, M., Althof, S., Assalian, P., Chevret-Measson, M., Leiblum, S., Simonelli, C., and, Wylie, K. 2010. Psychological and interpersonal dimensions of sexual function and dysfunction. Journal of Sexual Medicine, 7: 327-336.
31. McCabe, M., Price, E., Piterman, L., and, Lording, D. 2008. Evaluation of an Internet-based psychological intervention for the treatment of erectile dysfunction. International Journal of Impotence Research, 20: 324-330.
32. Mehrabi, F., Dadfar, M., and, Chimeh, N. 2006. The effectiveness of cognitive-behavioral techniques in the treatment of erectile dysfunction. Iranian Journal of Psychiatry and Clinical Psychology, 12: 9-15.
33. Melnik, T., and, Abdo, C. 2005. Psychogenic erectile dysfunction: Comparative study of three therapeutic approaches. Journal of Sex & Marital Therapy, 31: 243-225.
34. Melnik, T., Abdo, C., de Moraes, J., and, Riera, R. 2011. Satisfaction with the treatment, confidence and naturalness in engaging in sexual activity in men with psychogenic erectile dysfunction: Preliminary results of a randomized controlled trial of three therapeutic approaches. British Journal of Urology International, 109: 1213-1219.
35. Melnik, T., Soares, B., and, Nasselo, A. 2007. Psychosocial interventions for erectile dysfunction. Cochrane Database Systematic Review, 2007: CD004825
36. Mialon, A., Berchtold, A., Michaud, P., Gmel, G., and, Suris, J. 2012. Sexual dysfunctions among young men: Prevalence and associated factors. Journal of Adolescent Health, 51: 25-31.
37. Mitchell, J., and, Read, J. 2012. Attention-deficit hyperactivity disorder, drug companies and the Internet. Clinical Child Psychology and Psychiatry, 17: 121-139.
38. Moncrieff, J. 2006. Psychiatric drug promotion and the politics of neo-liberalism. British Journal of Psychiatry, 191: 82-83.
39. Morales, A., Surridge, D., Marshall, P., and, Fenemore, J. 1982. Nonhormonal pharmacological treatment of organic impotence. Journal of Urology, 128: 45-47.
40. Mosher, L., Gosden, R., and, Beder, S. 2013. " Drug companies and schizophrenia: Unbridled capitalism meets madness ". In Models of madness, 2nd ed., Edited by: Read, J. and Dillon, J. London, England: Routledge.
41. Moynihan, R., and, Cassels, A. 2005. Selling sickness: How the world's biggest pharmaceutical companies are turning us all into patients, New York, NY: Nation Books.
42. Murthy, S., and, Wylie, K. 2007. Sexual problems in patients on antipsychotic medication. Sexual and Relationship Therapy, 22: 97-107.
43. National Institute of Health. 1992. NIH consensus statement-Impotence, Bethesda, MD: Author.
44. Polusny, M. A., and, Follette, V. M. 1995. Long-term correlates of child sexual abuse: Theory and review of the empirical literature. Applied and Preventative Psychology, 4: 143-166.
45. Ponholzer, A., Temml, C., Mock, K., Marszalek, M., Obermayr, R., and, Madersbacher, S. 2005. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. European Urology, 47: 80-86.
46. Powell, J., and, Clarke, A. 2006. Internet information-seeking in mental health. British Journal of Psychiatry, 189: 273-277.
47. Read, J. 2008. Schizophrenia, drug companies and the Internet. Social Science & Medicine, 66: 99-109.
48. Read, J., Haslam, N., Sayce, L., and, Davies, E. 2006. Prejudice and schizophrenia: A review of the "mental illness is an illness like any other" approach. Acta Psychiatrica Scandinavica, 114: 303-318.
49. Read, J., Magliano, L., and, Beavan, V. 2013. " Public beliefs about the causes of "schizophrenia": Bad things happen and can drive you crazy ". In Models of madness, 2nd ed., Edited by: Read, J. and Dillon, J. London, England: Routledge.
50. Reavley, N., and, Jorm, A. 2011. The quality of mental disorder information websites: A review. Patient Education and Counselling, 85: 16-25.
51. Sharfstein, S. 2005. Big pharma and American psychiatry: The good, the bad, and the ugly. Psychiatric News, 40: 3-5.
52. Shooter, M. 2005. Dancing with the devil? A personal view of psychiatry's relationships with the pharmaceutical industry. Psychiatric Bulletin, 29: 81-83.
53. Toop, L., Richards, D., and, Dowell, T. 2003. The leadership role of general practice in public health: Advocating a ban of direct-to-consumer advertising of prescription drugs in New Zealand. British Journal of General Practice, 53: 342-345.
54. Travison, T., Shabsigh, R., Araujo, A., Kupelian, V., ODonnell, A., and, McKinlay, J. 2007. The natural progression and remission of erectile dysfunction: Results from the Massachusetts Male Aging Study. Journal of Urology, 177: 241-246.
55. Usher, W. 2010. Persuasion and types of enticements offered by pharmaceutical companies to Gold Coast general practitioners in an attempt to encourage a health website recommendation. Health and Social Care in the Community, 18: 100-105.
56. Woodlock, D. 2005. Virtual pushers: Antidepressant Internet marketing and women. Women's Studies International Forum, 28: 304-314.
57. Wylie, K. 1997. Treatment outcome of brief couple therapy on psychogenic male erectile disorder. Archives of Sexual Behavior, 26: 527-545.